1. Home
  2. BOX vs ADMA Comparison

BOX vs ADMA Comparison

Compare BOX & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$30.60

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.12

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
ADMA
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BOX
ADMA
Price
$30.60
$19.12
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$38.67
$28.50
AVG Volume (30 Days)
2.3M
2.3M
Earning Date
12-02-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
54.13
205.35
EPS
1.24
0.86
Revenue
$1,150,898,000.00
$488,559,000.00
Revenue This Year
$9.07
$22.19
Revenue Next Year
$7.74
$23.71
P/E Ratio
$24.27
$22.52
Revenue Growth
7.21
27.63
52 Week Low
$28.00
$13.50
52 Week High
$38.80
$25.67

Technical Indicators

Market Signals
Indicator
BOX
ADMA
Relative Strength Index (RSI) 51.28 53.64
Support Level $29.42 $18.33
Resistance Level $30.69 $19.94
Average True Range (ATR) 0.58 0.60
MACD 0.04 -0.19
Stochastic Oscillator 56.80 36.42

Price Performance

Historical Comparison
BOX
ADMA

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: